Skip to main content
SpringerLink
Log in

Men with Acquired Hypogonadotropic Hypogonadism Treated with Testosterone may be Fertile

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

Men with acquired hypogonadotropic hypogonadism treated with testosterone are generally assumed to be infertile. The finding of two such patients with unexpected fertility and normal sperm counts prompted an evaluation of spermatogenesis in additional men with this condition. Case records were initially searched and one similar case with fertility was found. Subsequently, 12 consecutive men with acquired hypogonadotropic hypogonadism were evaluated for gonadal function and sperm production while receiving testosterone. In five of the cases with proven spermatogenesis, exon 10 of the FSH receptor was sequenced to look for activating mutations.

The original three cases and four of the subsequent 12 men had sperm concentrations ≥15 million/ml. Two additional men had concentrations of 1 million/ml and six were azoospermic. Residual LH and FSH levels were slightly higher in those with maintained spermatogenesis prior to testosterone replacement. No activating mutations were found in exon 10 of the FSH receptor in the five cases studied.

We conclude that men with acquired hypogonadotropic hypogonadism being treated with testosterone should not be assumed to be sterile, as we have found that more than half have been shown to have persistent spermatogenesis with more than one-third having sperm concentrations ≥15 million/ml. This may be related to fact that gonadotropin levels in such patients are present, albeit low. Semen analyses in such men should be routinely carried out so that they can be appropriately counseled regarding potential fertility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Matsumoto AM. Hormonal therapy of male hypogonadism. Endocrinol Metab Clin N Amer 1994;23:857–875.

    Google Scholar 

  2. Hayes FJ, Seminara SB, Crowley WF Jr. Hypogonadotropic hypogonadism. Endocrinol Metab Clin N Amer 1998;27:739–763.

    Google Scholar 

  3. Winters SJ. Clinical disorders of the testis. In: DeGroot LJ, Jameson JL, eds., Endocrinology, 4th ed. Philadelphia: W. B. Saunders Co., 2001:2269–2290.

    Google Scholar 

  4. Gromoll J, Simoni M, Neischlag E. An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. J Clin Endocrinol Metab 1996;81:1367–1370.

    Google Scholar 

  5. Aittomäki K, Lucena JL, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J, Koskikari R, Sankila EM, Lehvarlaiho H, Engel AR. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995;82:959–968.

    Google Scholar 

  6. Simoni M, Gromoll J, Nieschlag E. The follicle-stimulating hormone receptor: Biochemistry, molecular biology, physiology, and pathophysiology. Endocrine Revs 1997;18:739–773.

    Google Scholar 

  7. Simoni M, Gromoll J, Höppner W, Kamischke A, Kraff T, Stahle D, Nieschlag E. Mutational analysis of the folliclestimulating hormone (FSH) receptor in normal and infertile men: Identification and characterization of two discrete FSH receptor isoforms. J Clin Endocrinol Metab 1999;84:751–755.

    Google Scholar 

  8. Tapanainen JS, Vaskivo T, Aittomäki K, Huhtamieni IT. Inactivating FSH receptor mutations and gonadal dysfunction. Mol Cell Endocrinol 1998;145:129–135.

    Google Scholar 

  9. Baranetsky NG, Carlson HE. Persistence of spermatogenesis in hypogonadotropic hypogonadism treated with testosterone. Fertil Steril 1980;34:477–482.

    Google Scholar 

  10. McLachlan RI, Wreford NG, O'Donnell L, de Kretser DM, Robertson DM. The endocrine regulation of spermatogenesis: Independent roles for testosterone and FSH. J Endocrinol 1996;148:1–9.

    Google Scholar 

  11. Zirkin BR. Spermatogenesis: Its regulation by testosterone and FSH. Cell & Devel Biol 1998;9:417–421.

    Google Scholar 

  12. Maroulis GB, Parlow AF, Marshall JR. Isolated FSH deficiency in a man. Fertil Steril 1997;28:818–822.

    Google Scholar 

  13. Hägg E, Tollin C, Bergman B. Isolated FSH deficiency in a male: A case report. Scand J Urol Nephrol 1978;12:287–289.

    Google Scholar 

  14. Mozaffarian GA, Higley M, Paulsen CA. Clinical studies in an adult male with isolated follicle-stimulating hormone (FSH) deficiency. J Androl 1983;4:393–398.

    Google Scholar 

  15. Al-Ansari AA-K, Khalil TH, Kelani Y, Mortimer CH. Isolated follicle-stimulating hormone deficiency in men: Successful long-term gonadotropin therapy. Fertil Steril 1984;42:618–626.

    Google Scholar 

  16. Diez JJ, Iglesias P, Sastre J, Salvadore J, Gomez-Pan A, Otero I, Granizo V. Isolated deficiency of follicle-stimulating hormone in man: A case report and literature review. Int J Fertil Menopausal Stud 1994;39:26–31.

    Google Scholar 

  17. Phillip M, Arbelle JE, Segev Y, Parvari R. Male hypogonadism due to a mutation in the gene for the β subunit of follicle-stimulating hormone. N Engl J Med 1998;338:1729–1732.

    Google Scholar 

  18. Linstedt G, Nystrom E, Matthews C, Ernest I, Janson PO, Chatterjee K. Follitropin (FSH) deficiency in an infertile male due to FSHβ gene mutation. A syndrome of normal puberty and virilization but underdeveloped testicles with azoospermia, low FSH but high lutropin and normal serum testosterone. Clin Chem Lab Med 1998;36:663–665.

    Google Scholar 

  19. Tapanainen JS, Aittomaki K, Minn J, Vaskivuo T, Huhtaniemi IT. Men homozygous for an inactivating mutation of the FSH receptor gene present with variable suppression of spermatogenesis and fertility. Nat Genet 1997;15: 205–206.

    Google Scholar 

  20. Finkel DM, Phillips JL, Snyder PJ. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. N Engl J Med 1985;313:651–655.

    Google Scholar 

  21. Burris AS, Robard HW, Winters SJ, Sherins RJ. Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: The response to human chorionic gonadotropin is predicted by initial testicular size. J Clin Endocrinol Metab 1988;66:1144–1151.

    Google Scholar 

  22. Vicari E, Mongioi A, Calogero AE, Moncada ML, Sidoti G, Polosa P, D'Agata R. Therapy with human chorionic gonadotropin alone induces spermatogenesis in men with isolated hypogonadotropic hypogonadism—long-term follow up. Int J Androl 1992;15:320–329.

    Google Scholar 

  23. Matusomoto AM, Bremner WJ. Stimulation of sperm production by human chorionic gonadotropin after prolonged gonadotropin suppression in normal men. J Androl 1985;6:137–143.

    Google Scholar 

  24. Matsumoto AM. Effects of chronic testosterone administration in normal men: Safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production. J Clin Endocrinol Metab 1990;70:282–287.

    Google Scholar 

  25. World Health Organization Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet 1990;336:955–959.

    Google Scholar 

  26. World Health Organization Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril 1996;65:821–829.

    Google Scholar 

  27. Cummings DE, Bremner WJ. Prospects for new hormonal male contraceptives. Endocrinol Metab Clin N Amer 1994;23:893–922.

    Google Scholar 

  28. Swerdloff RS, Bagatell CJ, Wang C, Anawalt BD, Berman N, Steiner B, Bremner WJ. Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone. J Clin Endocrinol Metab 1998;83:3526–3533.

    Google Scholar 

  29. Huang HFS, Marshall GR, Rosenberg R, Nieschlag E. Restoration of spermatogenesis by high levels of testosterone in hypophysectomized rats after long term regression. Acta Endocrinol 1987;116:433–444.

    Google Scholar 

  30. Sun Y-T, Irby DC, Robertson DM, de Kretser DM. The effects of exogenously administered testosterone on spermatogenesis in intact and hypophysectomized rats. Endocrinology 1989;125:1000–1010.

    Google Scholar 

  31. Marshall GR, Wickings EJ, Ludecke DK, Nieschlag E. Stimulation of spermatogenesis in stalk-sectioned Rhesus monkeys by testosterone alone. J Clin Endocrinol Metab 1983;57:152–159.

    Google Scholar 

  32. Marshall GR, Zorub DS, Plant TM. Follicle-stimulating hormone amplifies the population of differentiated spermatogonia in the hypophysectomized testosterone-replaced adult rhesus monkey (Macaca mulatto). Endocrinology 1995;136:3504–3511.

    Google Scholar 

  33. Handelsman DJ, Spaliviero JA, Simpson JM, Allan CM, Singh J. Spermatogenesis without gonadotropins: Maintenance has a lower testosterone threshold than initiation. Endocrinology 1999;140:3938–3946.

    Google Scholar 

  34. Schaison G, Young J, Pholsena M, Nahoul K, Couzinet B. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1993;77:1545–1549.

    Google Scholar 

  35. Drincic A, Molitch ME. Hypogonadotropic hypogonadal men treated with testosterone may be fertile. Presented at the 80th Annual Meeting of the Endocrine Society, New Orleans. Abstract #P2-035. 1998.

  36. Drincic A, Arseven OK, Sosa E, Mercado M, Kopp P, Molitch ME. Men with acquired hypogonadotropic hypogonadism treated with testosterone may be spontaneously fertile. Presented at the Eighth Internation Pituitary Congress, New York, June, 2003.

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University, The Feinberg Medical School, Chicago, Illinois, USA

    Andjela Drincic, Onur Karamanoglu Arseven, Peter Kopp & Mark E. Molitch

  2. Endocrinology Section/Experimental Endocrinology Laboratory, Hospital de Especialidades, Centro Medico Nacional, IMSS, Mexico City, Mexico

    Ernesto Sosa & Moises Mercado

Authors
  1. Andjela Drincic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Onur Karamanoglu Arseven
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ernesto Sosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Moises Mercado
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Peter Kopp
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mark E. Molitch
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drincic, A., Arseven, O.K., Sosa, E. et al. Men with Acquired Hypogonadotropic Hypogonadism Treated with Testosterone may be Fertile. Pituitary 6, 5–10 (2003). https://doi.org/10.1023/A:1026232124988

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026232124988

Search

Navigation